This report contains market size and forecasts of Sturge Weber Syndrome (SWS) Treatment in Global, including the following market information:
Global Sturge Weber Syndrome (SWS) Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Sturge Weber Syndrome (SWS) Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Sturge Weber Syndrome (SWS) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sturge Weber Syndrome (SWS) Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Sturge Weber Syndrome (SWS) Treatment Market Segment Percentages, By Type, 2020 (%)
Medication
Laser Therapy
Surgical Procedures
China Sturge Weber Syndrome (SWS) Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Sturge Weber Syndrome (SWS) Treatment Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Diagnostic Centers
Others
Global Sturge Weber Syndrome (SWS) Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Sturge Weber Syndrome (SWS) Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Sturge Weber Syndrome (SWS) Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Sturge Weber Syndrome (SWS) Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott
Pfizer
Roche
Novartis
Johnson & Johnson
UCB
Sanofi
Takeda
Aleva Neurotherapeutics
GW Pharmaceuticals
ElectroCore
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Sturge Weber Syndrome (SWS) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sturge Weber Syndrome (SWS) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sturge Weber Syndrome (SWS) Treatment Overall Market Size
2.1 Global Sturge Weber Syndrome (SWS) Treatment Market Size: 2021 VS 2027
2.2 Global Sturge Weber Syndrome (SWS) Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sturge Weber Syndrome (SWS) Treatment Players in Global Market
3.2 Top Global Sturge Weber Syndrome (SWS) Treatment Companies Ranked by Revenue
3.3 Global Sturge Weber Syndrome (SWS) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Sturge Weber Syndrome (SWS) Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Sturge Weber Syndrome (SWS) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sturge Weber Syndrome (SWS) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Sturge Weber Syndrome (SWS) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Sturge Weber Syndrome (SWS) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Sturge Weber Syndrome (SWS) Treatment Market Size Markets, 2021 & 2027
4.1.2 Medication
4.1.3 Laser Therapy
4.1.4 Surgical Procedures
4.2 By Type - Global Sturge Weber Syndrome (SWS) Treatment Revenue & Forecasts
4.2.1 By Type - Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2021
4.2.2 By Type - Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2022-2027
4.2.3 By Type - Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sturge Weber Syndrome (SWS) Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Sturge Weber Syndrome (SWS) Treatment Revenue & Forecasts
5.2.1 By Application - Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2021
5.2.2 By Application - Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2022-2027
5.2.3 By Application - Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Sturge Weber Syndrome (SWS) Treatment Market Size, 2021 & 2027
6.2 By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue & Forecasts
6.2.1 By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2021
6.2.2 By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2022-2027
6.2.3 By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2027
6.3.2 US Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.3.3 Canada Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.3.4 Mexico Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2027
6.4.2 Germany Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4.3 France Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4.4 U.K. Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4.5 Italy Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4.6 Russia Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.4.8 Benelux Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2027
6.5.2 China Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.5.3 Japan Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.5.4 South Korea Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.5.6 India Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2027
6.6.2 Brazil Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.6.3 Argentina Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2027
6.7.2 Turkey Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.7.3 Israel Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
6.7.5 UAE Sturge Weber Syndrome (SWS) Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.1.4 Abbott Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.1.5 Abbott Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.2.4 Pfizer Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.3.4 Roche Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.3.5 Roche Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.4.4 Novartis Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.5.4 Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 UCB
7.6.1 UCB Corporate Summary
7.6.2 UCB Business Overview
7.6.3 UCB Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.6.4 UCB Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.6.5 UCB Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.4.4 Sanofi Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Takeda
7.8.1 Takeda Corporate Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.8.4 Takeda Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.8.5 Takeda Key News
7.9 Aleva Neurotherapeutics
7.9.1 Aleva Neurotherapeutics Corporate Summary
7.9.2 Aleva Neurotherapeutics Business Overview
7.9.3 Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.9.4 Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.9.5 Aleva Neurotherapeutics Key News
7.10 GW Pharmaceuticals
7.10.1 GW Pharmaceuticals Corporate Summary
7.10.2 GW Pharmaceuticals Business Overview
7.10.3 GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.10.4 GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.10.5 GW Pharmaceuticals Key News
7.11 ElectroCore
7.11.1 ElectroCore Corporate Summary
7.11.2 ElectroCore Business Overview
7.11.3 ElectroCore Sturge Weber Syndrome (SWS) Treatment Major Product Offerings
7.11.4 ElectroCore Sturge Weber Syndrome (SWS) Treatment Revenue in Global (2016-2021)
7.11.5 ElectroCore Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Sturge Weber Syndrome (SWS) Treatment Market Opportunities & Trends in Global Market
Table 2. Sturge Weber Syndrome (SWS) Treatment Market Drivers in Global Market
Table 3. Sturge Weber Syndrome (SWS) Treatment Market Restraints in Global Market
Table 4. Key Players of Sturge Weber Syndrome (SWS) Treatment in Global Market
Table 5. Top Sturge Weber Syndrome (SWS) Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Sturge Weber Syndrome (SWS) Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Sturge Weber Syndrome (SWS) Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Sturge Weber Syndrome (SWS) Treatment Product Type
Table 9. List of Global Tier 1 Sturge Weber Syndrome (SWS) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sturge Weber Syndrome (SWS) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Sturge Weber Syndrome (SWS) Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Sturge Weber Syndrome (SWS) Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Sturge Weber Syndrome (SWS) Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Sturge Weber Syndrome (SWS) Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Corporate Summary
Table 31. Abbott Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 32. Abbott Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 35. Pfizer Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Roche Corporate Summary
Table 37. Roche Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 38. Roche Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Novartis Corporate Summary
Table 40. Novartis Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 41. Novartis Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 44. Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 45. UCB Corporate Summary
Table 46. UCB Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 47. UCB Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 50. Sanofi Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Takeda Corporate Summary
Table 52. Takeda Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 53. Takeda Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Aleva Neurotherapeutics Corporate Summary
Table 55. Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 56. Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 57. GW Pharmaceuticals Corporate Summary
Table 58. GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 59. GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
Table 60. ElectroCore Corporate Summary
Table 61. ElectroCore Sturge Weber Syndrome (SWS) Treatment Product Offerings
Table 62. ElectroCore Sturge Weber Syndrome (SWS) Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Sturge Weber Syndrome (SWS) Treatment Segment by Type
Figure 2. Sturge Weber Syndrome (SWS) Treatment Segment by Application
Figure 3. Global Sturge Weber Syndrome (SWS) Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Sturge Weber Syndrome (SWS) Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Sturge Weber Syndrome (SWS) Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sturge Weber Syndrome (SWS) Treatment Revenue in 2020
Figure 8. By Type - Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 12. US Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 24. China Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Sturge Weber Syndrome (SWS) Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Sturge Weber Syndrome (SWS) Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Roche Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Novartis Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Johnson & Johnson Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. UCB Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Sanofi Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Takeda Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Aleva Neurotherapeutics Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. GW Pharmaceuticals Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. ElectroCore Sturge Weber Syndrome (SWS) Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Abbott
Pfizer
Roche
Novartis
Johnson & Johnson
UCB
Sanofi
Takeda
Aleva Neurotherapeutics
GW Pharmaceuticals
ElectroCore